News
Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers
Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.
Faced with a shrinking buyer pool, sellers are beginning to feel pressure to cut prices, with 56% of homes selling below ...
After years of steady increases, the median list price for a home in the United States has finally dropped — if only a little, according to Realtor.com’s June Housing Report.
U.S. Sen. Bernie Sanders, I-Vt., and U.S. Rep. Cori Bush, D-Mo., introduced legislation earlier this month that would limit the list price of insulin to $20 per vial.
The list price is simply the price that an item is listed to be sold for. For instance, if you run a T-shirt shop, the list price of a pink shirt might be $24.95.
List prices increased an average of 9.1% per year, but increasing discount practices have limited net price increases to just 4.5% By Emily Payne | March 06, 2020 at 10:15 AM ...
In a study of both list and net price by IQVIA (formerly called IMS), the list price of brand drugs grew by 11.3 percent in 2013 and 6.9 percent in 2017, whereas net price grew by 4.7 percent ...
List prices are not a good indicator of what patients will pay, because their insurers determine what they pay out of pocket. Instead, we want to provide cost information in a comprehensive fashion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback